[1]
Bozdag, M.; Altamimib, A.S.A.; Daniela Vullo, A.; Supuran, C.T.; Carta, F. State of the Art on Carbonic Anhydrase Modulators for Biomedical Purposes. Curr. Med. Chem., 2019. 26(15), 2558-2573.
[2]
Ciubotaru, M.; Musat, M.G.; Surleac, M.; Elena Ionita, E.; Petrescu, A.J.; Abele, E.; Abele, R. The Design of New HIV-IN Tethered Bifunctional Inhibitors Using Multiple Microdomain Targeted Docking. Curr. Med. Chem., 2019. 26(15), 2574-2600.
[3]
Helberth Llantén Martínez, H.; Leonardo, E.; Riafrecha, L.E. Colinas, P.A. C-cinnamoyl glycosides: an emerging “tail” for the development of selective carbonic anhydrase inhibitors. Curr. Med. Chem., 2019. 26(15), 2601-2608.
[4]
Cerofolini, L.; Fragai, M.; Luchinat, C. Mechanism and Inhibition of Matrix Metalloproteinases. Curr. Med. Chem., 2019. 26(15),
2609-2633.
[5]
Swingle, M.R.; Honkanen, R.E. Inhibitors of Serine/Threonine Protein Phosphatases: Biochemical and Structural Studies Provide Insight for Further Development. Curr. Med. Chem., 2019. 26(15), 2634-2660.
[6]
Camodeca, C.; Cuffaro, D.; Nuti, E.; Rossello, A. ADAM metalloproteinases as potential drug targets. Curr. Med. Chem., 2019. 26(15), 2661-2689.
[7]
Raivis Žalubovskis, R.; Winum, J-Y. Inhibitors of Selected Bacterial Metalloenzymes. Curr. Med. Chem., 2019. 26(15), 2690-2714.
[8]
Georgiadis, D.; Mpakali, A.; Koumantou, D.; Stratikos, E. Inhibitors of ER Aminopeptidase 1 and 2: from Design to Clinical Application. Curr. Med. Chem., 2019. 26(15), 2715-2729.
Related Journals
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
Article Metrics
26
5
1